UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040165
Receipt number R000045793
Scientific Title Study on the behavior of plasma microRNA145, microRNA143, progranulin and exosome
Date of disclosure of the study information 2022/05/01
Last modified on 2025/10/19 14:54:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the behavior of plasma microRNA145, microRNA143, progranulin and exosome

Acronym

Study on the behavior of plasma microRNA145, microRNA143, progranulin and exosome

Scientific Title

Study on the behavior of plasma microRNA145, microRNA143, progranulin and exosome

Scientific Title:Acronym

Study on the behavior of plasma microRNA145, microRNA143, progranulin and exosome

Region

Japan


Condition

Condition

cardiac patients (coronary artery disease, dilated cardiomyopathy, hypertrophic cardiomyopathy, valvular disease, myocardial infarction)

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the relationship between plasma microRNA145, microRNA143, progranulin,
exosome and cardiac function

Basic objectives2

Others

Basic objectives -Others

Effect of plasma microRNA145, microRNA143, progranulin and exosome on cardiac function in the chronic phase in patients with acute myocardial infarction

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the relationship between plasma microRNA145, microRNA143, progranulin,
exosome and cardiac function

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Cardiac patents (coronary artery disease, dilated cardiomyopathy, hypertrophic cardiomyopathy, valvular heart disease, myocardial infarction)

Patients with written informed consent

Key exclusion criteria

patients judged as inappropriate by
the doctor

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Shinya
Middle name
Last name Minatoguchi

Organization

Gifu University

Division name

Department of Circulatory and Respiratory Advanced Medicine

Zip code

501-1194

Address

1-1 Yanagido, Gifu City, Gifu Prefecture

TEL

058-230-6523

Email

minatos@gifu-u.ac.jp


Public contact

Name of contact person

1st name Shinya
Middle name
Last name Minatoguchi

Organization

Gifu University

Division name

Department of Circulatory and Respiratory Advanced Medicine

Zip code

501-1194

Address

1-1 Yanagido, Gifu City, Gifu Prefecture

TEL

058-230-6523

Homepage URL


Email

minatos@gifu-u.ac.jp


Sponsor or person

Institute

Gifu University

Institute

Department

Personal name



Funding Source

Organization

Gifu University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical comittee Gifu Univetsity School of Medicine

Address

1-1 Yanagido, Gifu City, Gifu Prefecture

Tel

058-230-6059

Email

rinri@gifu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 01 Day


Related information

URL releasing protocol

doi: 10.1253/circj.CJ-22-0698

Publication of results

Partially published


Result

URL related to results and publications

doi: 10.1253/circj.CJ-22-0698

Number of participants that the trial has enrolled

45

Results

The increase in plasma miR-143 concentrations in the acute phase was positively correlated with the increase in LVEF in the chronic phase. Among many factors, only the increase in miR-143 was favorably correlated with left ventricle (LV) functional recovery in the chronic phase

Results date posted

2025 Year 10 Month 19 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2023 Year 11 Month 01 Day

Baseline Characteristics

The increase in plasma miR-143 concentrations in  the acute phase was positively correlated with the increase in LVEF in the chronic phase. Among many factors, only the increase in miR-143 was favorably correlated with left ventricle (LV) functional recovery in the chronic phase

Participant flow

he increase in plasma miR-143 concentrations in the acute phase was positively correlated with the increase in LVEF in the chronic phase. Among many factors, only the increase in miR-143 was favorably correlated with left ventricle (LV) functional recovery in the chronic phase

Adverse events

non

Outcome measures

plasma miR-143 concentration, left ventricular ejection fraction

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 04 Month 04 Day

Date of IRB

2018 Year 04 Month 04 Day

Anticipated trial start date

2023 Year 03 Month 31 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We aim to clarify the relationship between plasma microRNA145, microRNA143, progranulin, exosome and cardiac function in cardiac patients.


Management information

Registered date

2020 Year 04 Month 15 Day

Last modified on

2025 Year 10 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045793